Your browser doesn't support javascript.
loading
Clinical and Serological Characterization of Orf-Induced Immunobullous Disease.
Yilmaz, Kaan; Goletz, Stephanie; Pas, Henri H; van den Bos, Renate R; Blauvelt, Andrew; White, Wain L; Bouaziz, Jean-David; Zuelgaray, Elina; Daneshpazhooh, Maryam; Yancey, Kim B; Goebeler, Matthias; Schmidt, Enno.
Afiliação
  • Yilmaz K; Department of Dermatology, University of Lübeck, Lübeck, Germany.
  • Goletz S; Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany.
  • Pas HH; Department of Dermatology, University of Groningen, Groningen, the Netherlands.
  • van den Bos RR; Department of Dermatology, Erasmus MC, Rotterdam, the Netherlands.
  • Blauvelt A; Department of Dermatology, Oregon Health & Science University, Portland.
  • White WL; Aurora Diagnostics, GPA Laboratories, Greensboro, North Carolina.
  • Bouaziz JD; Dermatology Department, AP-HP, St-Louis Hospital, University of Paris, Paris, France.
  • Zuelgaray E; Dermatology Department, AP-HP, St-Louis Hospital, University of Paris, Paris, France.
  • Daneshpazhooh M; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Yancey KB; Department of Dermatology, UT Southwestern Medical Center in Dallas, Dallas, Texas.
  • Goebeler M; Department of Dermatology, University of Würzburg, Würzburg, Germany.
  • Schmidt E; Department of Dermatology, University of Lübeck, Lübeck, Germany.
JAMA Dermatol ; 158(6): 670-674, 2022 06 01.
Article em En | MEDLINE | ID: mdl-35353128
ABSTRACT
Importance Ecthyma contagiosum, or orf, is a viral zoonotic infection caused by Poxviridae. Although human orf infection is considered to follow a self-limited course, various immunological reactions may be triggered, including immunobullous diseases. In the majority of the latter cases, the antigenic target remained enigmatic.

Objective:

To characterize the predominant autoantigen in orf-induced immunobullous disease and further describe this clinical entity. Design, Setting, and

Participants:

This multicenter case series sought to provide detailed clinical, histopathological and immunological characteristics of a patient with orf-induced pemphigoid. Based on this index patient, serological analyses were conducted of 4 additional patients with previously reported orf-induced immunobullous disease. Immunoblotting with extracellular matrix and a recently established indirect immunofluorescence assay for detection of serum anti-laminin 332 IgG were performed. Exposures The disease course and clinical characteristics of orf-induced immunobullous disease were observed. Main Outcomes and

Measures:

Orf-induced immunobullous disease is primarily characterized by anti-laminin 332 autoantibodies, predominant skin involvement, and a self-limiting course. The study provides further details on epidemiological, clinical, immunopathological, diagnostic, and therapeutic aspects of orf-induced immunobullous disease.

Results:

In all 5 patients, IgG1 and/or IgG3 autoantibodies against laminin 332 were identified. The α3, ß3, and γ2 chains were recognized in 2, 4, and 1 patient(s), respectively. Conclusions and Relevance In this case series, laminin 332, a well-known target antigen in mucous membrane pemphigoid, was a major autoantigen in orf-induced immunobullous disease, even though predominant mucosal lesions were lacking in this autoimmune blistering disease. Orf-induced anti-laminin 332 pemphigoid is proposed as distinct clinical entity.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Penfigoide Mucomembranoso Benigno / Penfigoide Bolhoso Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: JAMA Dermatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Penfigoide Mucomembranoso Benigno / Penfigoide Bolhoso Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: JAMA Dermatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha